IFNB1 and COVID-19: A previous study proposed that the Bacteroidetes phylum, which is reduced in severe and critically ill patients with COVID-19, could activate colonic dendritic cells through the TLR4-TRIF pathway using its bacterial outer membrane glycolipids and promote dendritic cells to secrete IFNβ to enhance host resistance against viral infection (Stefan et al., 2020).